Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 65

  1. Cat.No. Product Name Information/Activity
  2. BCC2676 H-D-Ser-OH (R)-Serine, an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor. (R)-Serine has a cardinal modulatory role in major NMDAR-dependent processes including NMDAR-mediated neurotransmission, neurotoxicity, synaptic plasticity, and cell migration. H-D-Ser-OH chemical structure
  3. BCC6864 Spermine tetrahydrochloride Spermine tetrahydrochloride is an endogenous metabolite. Spermine tetrahydrochloride chemical structure
  4. BCC6590 (1S,3R)-ACPD 111900-32-4 (1S,3R)-ACPD chemical structure
  5. BCC6567 (±)-trans-ACPD trans-ACPD, a metabotropic receptor agonist, produces calcium mobilization and an inward current in cultured cerebellar Purkinje neurons. (±)-trans-ACPD chemical structure
  6. BCC6910 CHPG CHPG is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways. CHPG chemical structure
  7. BCC7755 CHPG Sodium salt CHPG sodium salt is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG sodium salt protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways.. CHPG Sodium salt chemical structure
  8. BCC6613 (RS)-3,5-DHPG 19641-83-9 (RS)-3,5-DHPG chemical structure
  9. BCC6802 (S)-3,5-DHPG 162870-29-3 (S)-3,5-DHPG chemical structure
  10. BCC6604 (RS)-3-Hydroxyphenylglycine 31932-87-3 (RS)-3-Hydroxyphenylglycine chemical structure
  11. BCC6605 (S)-3-Hydroxyphenylglycine 71301-82-1 (S)-3-Hydroxyphenylglycine chemical structure

Items 641 to 650 of 752 total